VIDEO-MADE
Research type
Research Study
Full title
A Pragmatic, Off-Label, Randomised Controlled Trial of Variable Inhaled Corticosteroid Dosing by Blood Eosinophil level and Medication Adherence Digital Evaluation in Airways Disease
IRAS ID
1004465
Contact name
Dr Neil Greening
Contact email
Sponsor organisation
University of Leicester
Eudract number
2021-005934-41
ISRCTN Number
ISRCTN14101933
Research summary
An estimated 65 million people have moderate to severe chronic airway disease worldwide and about 334 million suffer from asthma. One of the most common ways of treating chronic airway diseases is providing patients with inhalers. However, we also know that one of the barriers to the management of chronic airway diseases is making sure that patients maintain good compliance with their medication. One way that we might be able to improve the management of chronic airway diseases is by helping patients to be more compliant with their medication. This trial aims to find out if there is any improvement in managing chronic airway disease (which will be measured by the number of severe exacerbations people experience) by using a smartphone app and smart inhaler to remind patients when and how often to use their medication. The smartphone app is designed to help with more frequent monitoring of symptoms and people’s compliance with medication use, and it is connected to a smart inhaler which will be used to deliver a medication regime that is tailored to the individual. This will be compared with a group of other individuals who will continue to receive their normal standard routine care.
REC name
North East - Tyne & Wear South Research Ethics Committee
REC reference
22/NE/0110
Date of REC Opinion
5 Aug 2022
REC opinion
Further Information Favourable Opinion